A diagnostic stewardship initiative to improve diagnosis of norovirus and nitazoxanide utilization in patients with cancer.
Nov 5, 2026DOI: 10.1017/ice.2026.10605Journal ArticleICHE
Written by: Guy HandleyChin-Ting WuJovan BorjanAlyssa FlukerAmin M AlousiPatricia MunzyAmeera MunzySherry CantuNancy VuongJavier AdachiMicah BhattiRoy F ChemalyAmy Spallone
Patients and healthcare workers are at risk of norovirus infection. Nitazoxanide is often given, though data is lacking. Multiplex polymerase chain reaction platforms may yield false-positive results. A quality improvement initiative led to an 84.4% reduction in nitazoxanide utilization and substantial cost savings without compromising patient care or nosocomial infection.